Street Calls of the Week
Director Kenneth Krogulski of Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), a $51.31 million market cap company that has delivered an impressive 163.85% return over the past year, acquired shares of common stock in a series of transactions between August 1, 2025, and August 29, 2025. The total purchase amounted to $4516, with individual prices ranging from $2.84 to $4.01, below the current trading price of $3.43.
Krogulski purchased a total of 1356 shares of Cumberland Pharmaceuticals common stock. Each transaction involved the purchase of either 68 or 12 shares. The purchases were executed on various dates throughout August: August 1, 4, 5, 6, 7, 8, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 25, 26, 27, 28 and 29. According to InvestingPro analysis, the stock is currently trading near its Fair Value, with 8 additional key insights available to subscribers.
Following these transactions, Krogulski directly owns 289717 shares of Cumberland Pharmaceuticals Inc. The purchases were made under a pre-arranged 10b5-1 trading plan adopted on November 14, 2024. Get comprehensive insights into CPIX’s valuation, financial health, and growth potential with the detailed Pro Research Report, available exclusively on InvestingPro.
In other recent news, Cumberland Pharmaceuticals Inc. reported a 10% year-over-year increase in revenue for the second quarter of 2025, totaling $10.8 million. Despite this positive revenue growth, the company’s earnings per share (EPS) did not meet expectations, registering a loss of $0.02. This earnings shortfall has been noted by analysts and contributed to a decline in investor sentiment. The company’s stock has experienced volatility, trading near the lower end of its 52-week range. Analysts from various firms have been closely monitoring these developments. Cumberland Pharmaceuticals’ financial results are a key focus for investors looking to understand the company’s current standing. These recent developments highlight the challenges the company faces amid its revenue growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.